Villejuif

• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• Liver-directed chemotherapy after surgery of liver metastases of colorectal cancer in patients with high risk of recurrence of their disease … Pending
  2025-523913-27-00 5 Participants with R0/R1 resected liver metastases from colorectal canc
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults with Advanced Colorectal Cancer. Pending
  2025-523984-39-00 4 Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC)
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ … Pending
  2025-524095-27-00 4 HER2-negative, unresectable, recurrent, and/or metastatic gastric, GEJ
• A study of cemsidomide and dexamethasone in subjects with relapsed or refractory multiple myeloma (r/r MM) Pending
  2025-524181-26-00 4 relapsed/refractory multiple myeloma
• TAILORswitch (PADA-2): rising ctDNA to tailor endocrine therapy switch in patients with ER+/HER2- metastatic breast cancer. Pending
  2025-524213-84-00 5 Patients with advanced or metastatic ER+ HER2- breast cancer
• REGENOVAR: A Phase I/II Study of Ubamatamab Plus Carboplatin, Paclitaxel, and Bevacizumab as Salvage Therapy in Ovarian Cancer with Poor Res … Pending
  2025-524232-20-00 7 Patients with poor prognostic ovarian cancers based on the tumor prima
• Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation A … Pending
  2025-524378-40-00 4 Locally advanced high‑risk stage III rectal adenocarcinoma (non‑metast
• An experimental trial to learn about hu14.18K322A treatment in children and adolescents with high-risk neuroblastoma. Pending
  2025-524397-42-00 10 Participants with relapsed HRNB and participants with HRNB refractory
• A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder. Pending
  2025-524488-18-00 4 Muscle-invasive Bladder Cancer
• A Research Study Testing New Cancer Medicines Used Alone or Together to Treat Solid Tumors Pending
  2025-524623-50-00 9 Solid Tumors
• Symbiotic-Lung-14: A Study to Learn About the Study Medicine called PF-08634404 in Combination With Chemotherapy in Adult Participants With … Pending
  2025-524686-24-00 4 Small Cell Lung Cancer
• Open-label study of BBO-11818 in adult subjects with KRAS mutant cancer Pending
  2025-524690-16-00 1 Solid Tumors
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• A Phase 1b-2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of LRK-4189 Alone and … Pending
  2026-525629-20-00 9 Solid tumors
• A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma Recruiting
  2025-523815-12-00 5 2026-07-06 Relapsed or Refractory Multiple Myeloma
• A clinical trial of ifinatamab deruxtecan in people under age 18 who have certain types of cancer (MK-9999-01D) Recruiting
  2025-522339-32-00 9 2026-06-30 Neoplasm malignant
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Recruiting
  2025-520565-51-00 5 2026-06-23 small cell lung cancer
• A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Recruiting
  2025-523576-23-00 5 2026-06-12 Unresectable Stage III non-small cell lung cancer without progression
• Study to assess how safe and effective is HRX215 in participants who underwent minor and major liver surgery due to colon carcinoma metastas … Recruiting
  2025-523630-59-00 9 2026-06-12 colon carcinoma metastases
• First time in human (FTIH) study to investigate the safety and preliminary activity of GSK5533524 alone or in combination in adult participa … Recruiting
  2025-524165-25-00 1 2026-06-10 Neoplasms
• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) (RASolute 304) Recruiting
  2025-523495-23-00 5 2026-06-09 Resected Pancreatic Ductal Adenocarcinoma (PDAC)
• A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect … Recruiting
  2025-523521-18-00 5 2026-06-09 Metastatic Colorectal Cancer
• A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older with Locally Advanced or Metastatic … Recruiting
  2024-518871-74-00 4 2026-06-08 Locally Advanced or Metastatic Solid Tumours that harbour MET Amplific

Showing 49–72 of 978 trials